GSK Consumer Unit Holds Promise In 2008 As Rx Division Faces Challenges

GlaxoSmithKline sees consumer health care as a major opportunity in 2008 as its pharmaceutical division faces setbacks from increased generic competition and safety concerns surrounding the diabetes drug Avandia